본문 바로가기 주메뉴 바로가기
22대 대한민국 국회 국회정보길라잡이 국회의원검색
회원가입 로그인
HOME

정보검색

소장정보 검색

국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

고급검색

인명/단체명

저자정보 상세정보
인명/단체명을 입력하세요.

키워드

  • 대표어

  • 외국어

-

초록보기

Purpose This study aimed to evaluate the risk of locoregional failure after reduced dose selective neck irradiation (RD-SNI) in patients with oropharyngeal cancer (OPC).

Materials and Methods Between 2008 and 2022, 342 OPC patients underwent definitive radiation therapy (with or without concurrent systemic therapy). The doses of 67.2-68.4 Gy to gross tumor volume (GTV), 56-60 Gy to high-risk clinical target volumes (CTVHR), and 32-36 Gy to low-risk clinical target volumes (CTV-LR) were irradiated. The same target delineation and dosing policy were applied to all patients regardless of human papillomavirus (HPV) status. Oncological outcomes including failure patterns were also investigated.

Results With a median follow-up of 60.3 months (range, 1.4 to 196.6 months), the 3- and 5-year locoregional control, distant metastasis-free survival, disease-free survival, and overall survival rates were 91.6%/90.7%, 83.7%/80.7%, 78.7%/74.8%, and 91.0%/85.8%, respectively. The HPV-positive patients exhibited significantly better outcomes. Treatment failure occurred in 61 patients (17.8%); 37 (10.8%) had distant metastasis, 22 (6.4%) had local failure, and eight (2.3%) had regional failure. GTV failure was significantly more common in HPV-negative patients (p=0.003). Among the 27 patients with locoregional failure, either GTV and/ or CTV-HR failure occurred in 22 (81.5%), with CTV-LR failure in one (3.7%), and out-target regional (OTR) failure in five (18.5%). Only five failures (1.5%) could be attributed to the current RD-SNI policy: one CTV-LR failure (0.3%) reflecting the RD policy and four OTR failures (1.2%) reflecting the SNI policy.

Conclusion Excellent oncological outcomes were achieved with the current RD-SNI policy.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
Diagnostic challenges and clinical implications of microsatellite instability/mismatch repair deficiency in solid tumors Yoonjin Kwak, Jeong Mo Bae, Hye Seung Lee p. 1-14
Redefining HER2 in breast cancer : from conventional positivity to low and ultralow in the new era of antibody-drug conjugates Jiwon Koh, Seock-Ah Im p. 15-25
Understanding immune cell adaptation to tumor hypoxia for maximized therapeutic efficacy of immunotherapy : biology and non-invasive imaging application Taerim Oh, Minwoo Kim, Gi-Sue Kang, Sung-Joon Ye, Changhoon Choi, Won Park, Michael Hay, Hiroshi Hirata, G-One Ahn p. 26-47
Association of physical activity with dementia risk in cancer survivors : a Korean nationwide cohort study Su Kyoung Lee, Su Kyoung Lee, Minji Han, Sangwoo Park, Sun Jae Park, Jihun Song, Hye Jun Kim, Jaewon Kim, Hyeokjong Lee, Hyun-Young Shin, Kyae Hyung Kim, Sang Min Park p. 48-60
Long-term immunogenicity of the 13-valent pneumococcal conjugate vaccine during adjuvant chemotherapy in patients with gastric and colorectal cancer : a 5-year follow-up of a randomized controlled trial Hyeon-Jong Kim, Hyunjin Bang, Hyun-Jung Shim, Jun Eul Hwang, Sang-Hee Cho, Ik-Joo Chung, Seung Ji Kang, Jong Gwang Kim, Seung-Hoon Beom, A-Yeung Jang, Joon Young Song, Woo Kyun Bae p. 61-70
Elevated SLC3A2 expression promotes the progression of gliomas and enhances ferroptosis resistance through the AKT/NRF2/GPX4 axis Yuqian Zheng, Shaolong Zhou, Yiran Tao, Zimin Shi, Xiang Li, Xudong Fu, Jian Ma, Weihua Hu, Wulong Liang, Xinjun Wang p. 71-94
Reduced dose and selective neck irradiation policy in treating oropharynx cancer : excellent oncological outcomes with very low risk of locoregional failure Eunyeong Yang, Seung Gyu Park, Kyungmi Yang, Dongryul Oh, Yong Chan Ahn p. 95-106
Novel bronchoscopy method for molecular profiling of lung cancer : targeted washing technique Mi-Hyun Kim, Hayoung Seong, Hyojin Jang, Saerom Kim, Wanho Yoo, Soo Han Kim, Jeongha Mok, Kwangha Lee, Ki Uk Kim, Min Ki Lee, Jung Seop Eom p. 107-114
(The) profile of gut microbiota in carcinogenesis driven by mutant EGFR in non–small cell lung cancer Da-Som Kim, Eun Hye Kim, Ji Yong Kim, Dong Ha Kim, Yun Jung Choi, Jaeyi Jeong, Young Hoon Sung, Dong-Cheol Woo, Chong Jai Kim, Jae Cheol Lee, Miyong Yun, Jin-Yong Jeong, Jin Kyung Rho p. 115-127
(The) role of circulating tumor cell as a promising biomarker in the evaluation of pulmonary nodules : a prospective study Shijie Wang, Changdan Xu, Xiaohong Xu, Weipeng Shao, Guohui Wang, Xiongtao Yang, Liwei Gao, Feng Teng, Hongliang Sun, Yue Zhao, Hongxiang Feng, Guangying Zhu p. 128-140
Association between benign thyroid disorders and breast cancer risk in Korean women Boyoung Park, Thi Xuan Mai Tran p. 141-150
Ten-year follow-up clinical outcomes and the role of adjuvant chemotherapy in HER2-positive patients with microinvasive breast cancer Yeokyeong Shin, Soo-Young Lee, Hyehyun Jeong, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, BeomSeok Ko ... [et al.] p. 151-158
Elimusertib, a novel ATR inhibitor, induces anti-tumor effects through replication catastrophe in breast cancers Mudong Kim, Ahrum Min, Sohyeon Kim, Seongyeong Kim, Yu-jin Kim, Sujin Ham, Miso Lee, Eunice Yoojin Lee, Jinyong Kim, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im p. 159-174
Comparison of long-term oncological outcome of sentinel lymph node mapping methods (dye-only versus dye and radioisotope) in breast cancer patients following neoadjuvant chemotherapy Jinyoung Byeon, Changjin Lim, Eunhye Kang, Ji-Jung Jung, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han p. 175-181
Spatial transcriptomic landscape of brain metastases from triple-negative breast cancer : comparison of primary tumor and brain metastases using spatial analysis Jihwan Yoo, Inho Park, Hyun Jung Kim, Hun Ho Park, Sora Lee, Jee Hung Kim, Yoon Jin Cha p. 182-197
(The) impact of obesity on treatment outcomes in patients with hormone receptor–positive HER2-negative metastatic breast cancer receiving CDK 4/6 inhibitors Yoo Bin Jung, Hee Kyung Ahn, Hyun-Young Shin, Ji Hyung Hong, Chai Hong Rim p. 198-207
Adjuvant chemotherapy in breast cancer after neoadjuvant therapy : essential or optional? Di Zhang, Luo Yang, Yuan Zheng, Qi Zhou p. 208-220
Detection ability of quality of life changes and responsiveness of the KOQUSS-40 and the EORTC QLQ-C30/STO22 in patients who underwent gastrectomy : a prospective comparative study Bang Wool Eom, Keun Won Ryu, Ji Yeong An, Yun-Suhk Suh, In Cho, Sung Geun Kim, Ji-Ho Park, Hoon Hur, Hyung-Ho Kim, Sang-Hoon Ahn ... [et al.] p. 221-231
(The) effect of alcohol consumption behavior changes on gastric cancer risks stratified by sex in South Korea Yonghoon Choi, Jieun Jang, Hyeong Ho Jo, Nayoung Kim p. 232-241
Deciphering the risk of developing lung cancer after the diagnosis of gastric cancer with genetic evidence : a European and East Asian populations-based Mendelian randomization analysis Jiansheng Chen, Aiming Zeng, Yunzhe Yu, Sida Sun, Liqun Liao, Siwei Huang, Zhongshan Yang, Junfeng Zhou, Weijie Wu p. 242-251
Survival rates of patients with gastric cancer according to age and sex : a large-scale study using data from 14,739 patients Yonghoon Choi, Nayoung Kim, Ji Hyun Kim, Hyeong Ho Jo, Hyeon Jeong Oh, Hye Seung Lee, Yu Kyung Jun, Hyuk Yoon, Cheol Min Shin, Young Soo Park ... [et al.] p. 252-263
Molecular mosaics : unveiling heterogeneity in synchronous colorectal cancers Hyun Gu Lee, Yeseul Kim, Mi-Ju Kim, Yeon Wook Kim, Sun-Young Jun, Deokhoon Kim, In Ja Park, Seung-Mo Hong p. 264-274
Combined transarterial chemoembolization and external beam radiotherapy for identifying surgical candidates for hepatocellular carcinoma with macroscopic vascular invasion : a propensity score-weighted analysis Sumin Lee, Jinhong Jung, Jonggi Choi, So Yeon Kim, Jin Hyoung Kim, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Gi-Won Song, Jin-hong Park, Sang Min Yoon p. 275-283
(A) multicenter phase Ⅱ study of modified FOLFIRINOX for first-line treatment for advanced urachal cancer (ULTIMA; KCSG GU20-03) Inkeun Park, Jae Lyun Lee, Shinkyo Yoon, Sang Joon Shin, Seong-Hoon Shin, Jung Hoon Kim, Kwonoh Park, Hyo Jin Lee p. 284-291
Efficacy of chemotherapy following prior PARP-inhibitor treatment in patients with ovarian cancer Jung Chul Kim, Junsik Park, Yong Jae Lee, Eun Ji Nam, Sang Wun Kim, Sung-Hoon Kim, Young Tae Kim, Se Ik Kim, Jae-Weon Kim, Byoung-Gie Kim, Jung-Yun Lee p. 292-299
Cost-effectiveness analysis of daratumumab monotherapy and subsequent therapies in heavily treated relapsed/refractory multiple myeloma : a feasible methodology using a Korean nationwide population cohort Sung-Soo Park, Suein Choi, Seungpil Jung, Seunghoon Han, Chaehyeon Lee, Jinseon Han, Soyoung Kim, Kihyun Kim, Chang-Ki Min p. 300-310
Validating the Korean geriatric assessment tool in elderly multiple myeloma patients : a multicenter study Ji Yun Lee, Sang-A Kim, Youngil Koh, Ho-Young Yhim, Gyeong-Won Lee, Chang-Ki Min, Young Rok Do, Hyo Jung Kim, Sung Hwa Bae, Hyeon-Seok Eom ... [et al.] p. 311-319
Real-world experience of weekly carfilzomib in combination with cyclophosphamide and dexamethasone in multiple myeloma relapsed/refractory to bortezomib and lenalidomide Cheongin Yang, Changgon Kim, Kunye Kwak, Ka-Won Kang, Yong Park, Byung Soo Kim, Seong Hyun Jeong, Joon Seong Park, Yoon Seok Choi p. 320-328
Pilot study for feasibility of onco-geriatric intervention model in older patients with cancer in a tertiary academic hospital Jin Won Kim, Jung-Yeon Choi, Woochan Park, Minsu Kang, Jeongmin Seo, Eun Hee Jung, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim ... [et al.] p. 329-338
Exploring oncologists’ perspectives on the early integration of specialty palliative care in Korea : challenges, needs, and clinical implications Shin Hye Yoo, Yu Jung Kim, Ye Sul Jeung, Jung Sun Kim, Kwonoh Park, Eun Mi Nam, Si Won Lee, Jun Ho Ji, Jwa Hoon Kim, Joon Young Hur, Song Ee Park, Jung Lim Lee, Su-Jin Koh p. 339-348

추천서가 (다양한 추천 자료를 만나보세요)

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차

권호

기사명 원문보기 기사목차
닫기